Direct Oral Anticoagulants: Navigating Through Clinical Challenges-Reference-Cited by-同舟云学术

Direct Oral Anticoagulants: Navigating Through Clinical Challenges

Published:2023-08-08 Issue: Volume: Page:
ISSN:0920-3206
Container-title:Cardiovascular Drugs and Therapy
language:en
Short-container-title:Cardiovasc Drugs Ther

Author:

Ioannou Maria^ORCID,Leonidou Elena^ORCID,Chaziri Ioanna^ORCID,Mouzarou Angeliki^ORCID

Publisher

Springer Science and Business Media LLC

Subject

Pharmacology (medical),Cardiology and Cardiovascular Medicine,Pharmacology,General Medicine

Link

https://link.springer.com/content/pdf/10.1007/s10557-023-07499-0.pdf

Reference116 articles.

1. Rose DK, Bar B. Direct oral anticoagulant agents: pharmacologic profile, indications, coagulation monitoring, and reversal agents. J Stroke Cerebrovasc Dis: Off J Natl Stroke Assoc. 2018;27(8):2049–58.

2. Carnicelli AP, et al. Direct oral anticoagulants versus warfarin in patients with atrial fibrillation: patient-level network meta-analyses of randomized clinical trials with interaction testing by age and sex. Circulation. 2022;145(4):242–55.

3. Chen A, et al. Direct oral anticoagulant use: a practical guide to common clinical challenges. J Am Heart Assoc. 2020;9(13):e017559.

4. Direct oral anticoagulants: assessment report, European Medicines Agency. 2020. https://www.ema.europa.eu/en/documents/referral/assessment-report-article-53-procedure-direct-oral-anticoagulants-doacs_en.pdf. Accessed 19/04/2023.

5. Eliquis: EPAR – product information, European Medicines Agency. 2011. (Last updated: 09/09/2022). https://www.ema.europa.eu/en/documents/product-information/eliquis-epar-product-information_en.pdf. Accessed 19/04/2023.

Cited by 2 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Exploring the level of agreement among different drug-drug interaction checkers: a comparative study on direct oral anticoagulants;Expert Opinion on Drug Metabolism & Toxicology;2024-02-27

2. Open Issues in the Management of Otcagerian Patients with Atrial Fibrillation and Chronic Kidney Disease: Are we Ready for Left Atrial Appendage Occlusion (LAAO) as First-Line Therapy for Thromboembolic Risk Prevention?;Cardiovascular Drugs and Therapy;2024-01-26